Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Drug discovery company Recursion Pharmaceuticals raises $12.9mm in Series A round; adds $2.2mm to end round at $15.1mm

Executive Summary

Recursion Pharmaceuticals LLC (novel drug screening platform) raised $12.9mm in its Series A financing round led by Lux Capital. Obvious Ventures, Epic Ventures, Data Collective, AME Cloud Ventures, Wild Basin Investments, and other angel investors also participated.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
  • Digital Health
  • In Vitro Diagnostics
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register